To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples